Hap Trading, LLC Heron Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$4.63 - $9.94 $52,782 - $113,316	-11,400 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $35,070 - $52,920	-4,200 Reduced 26.92%	11,400 $5,000
Q3 2021 Nov 10, 2021	SELL	$10.13 - $15.0 $63,819 - $94,500	-6,300 Reduced 28.77%	15,600 $7,000
Q1 2020 May 08, 2020	BUY	$10.23 - $24.56 $224,037 - $537,864	21,900 New	21,900 $11,000
Q4 2019 Feb 11, 2020	SELL	$17.42 - $26.61 $181,168 - $276,744	-10,400 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$16.36 - $21.39 $170,144 - $222,456	10,400 New	10,400 $11,000
Q1 2019 May 10, 2019	SELL	$23.15 - $28.34 $236,130 - $289,068	-10,200 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$22.03 - $32.01 $2 Million - $2.9 Million	-90,600 Reduced 89.88%	10,200 $5,000
Q3 2018 Nov 09, 2018	SELL	$30.0 - $40.85 $51,000 - $69,445	-1,700 Reduced 1.66%	100,800 $16,000
Q2 2018 Aug 13, 2018	BUY	$26.4 - $42.0 $18,480 - $29,400	700 Added 0.69%	102,500 $335,000
Q1 2018 May 11, 2018	BUY	$18.43 - $28.8 $1.88 Million - $2.93 Million	101,800 New	101,800 $171,000

174

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $220M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.